TY - JOUR
T1 - Corrigendum
T2 - Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: The GRANT score applied to the ASSURE trial population [Ann Oncol., 28, (2017) (2747-2753)] DOI: 10.1093/annonc/mdx492
AU - Buti, S.
AU - Puligandla, M.
AU - Bersanelli, M.
AU - DiPaola, R. S.
AU - Manola, J.
AU - Taguchi, S.
AU - Haas, N. B.
N1 - Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - This study was coordinated by the ECOG-ACRIN Cancer Research Group (Peter J. O'Dwyer, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and supported by the National Cancer Institute of the National Institutes of Health under the following award numbers: CA180820 and CA180794. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.
AB - This study was coordinated by the ECOG-ACRIN Cancer Research Group (Peter J. O'Dwyer, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and supported by the National Cancer Institute of the National Institutes of Health under the following award numbers: CA180820 and CA180794. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.
UR - http://www.scopus.com/inward/record.url?scp=85051554799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051554799&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdx799
DO - 10.1093/annonc/mdx799
M3 - Comment/debate
C2 - 29608641
AN - SCOPUS:85051554799
SN - 0923-7534
VL - 29
SP - 1604
JO - Annals of Oncology
JF - Annals of Oncology
IS - 7
ER -
